{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:53:37Z","timestamp":1791665617042,"version":"4.3.4"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"European Union\u2019s Horizon 2020 Research and Innovation Program"},{"name":"Marie Sk\u0142odowska-Curie","award":["813707"],"award-info":[{"award-number":["813707"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Would the different regulatory approaches for preimplantation genetic testing (PGT) in Europe permit the implementation of preimplantation genetic testing using polygenic risk scores (PGT-P)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>While the regulatory approaches for PGT differ between countries, the space provided for potential implementation of PGT-P seems limited in all three regulatory models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>PGT is a reproductive genetic technology that allows the testing for hereditary genetic disorders and chromosome abnormalities in embryos before implantation. Throughout its history, PGT has largely been regarded as an ethically sensitive technology. For example, ethical questions have been raised regarding the use of PGT for adult-onset conditions, non-medical sex selection, and human leukocyte antigen typing for the benefit of existing siblings. Countries in which PGT is offered each have their own approach of regulating the clinical application of PGT, and a clear overview of legal and practical regulation of PGT in Europe is lacking. An emerging development within the field of PGT, namely PGT-P, is currently bringing new ethical tensions to the forefront. It is unclear whether PGT-P may be applied within the current regulatory frameworks in Europe. Therefore, it is important to investigate current regulatory frameworks in Europe and determine whether PGT-P fits within these frameworks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>The aim of this study was to provide an overview of the legal and practical regulation of the use of PGT in seven selected European countries (Belgium, France, Germany, Italy, the Netherlands, Spain, and the UK) and critically analyse the different approaches with regards to regulatory possibilities for PGT-P. Between July and September 2023, we performed a thorough and extensive search of websites of governments and governmental agencies, websites of scientific and professional organizations, and academic articles in which laws and regulations are described.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>We investigated the legal and regulatory aspects of PGT by analysing legal documents, regulatory frameworks, scientific articles, and guidelines from scientific organizations and regulatory bodies to gather relevant information about each included country. The main sources of information were national laws relating to PGT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>We divided the PGT regulation approaches into three models. The regulation of PGT differs per country, with some countries requiring central approval of PGT for each new indication (the medical indication model: the UK, the Netherlands), other countries evaluating each individual PGT request at the local level (the individual requests model: France, Germany), and countries largely leaving decision-making about clinical application of PGT to healthcare professionals (the clinical assessment model: Belgium, Italy, Spain). In the countries surveyed that use the medical indication model and the individual requests model, current legal frameworks and PGT criteria seem to exclude PGT-P. In countries using the clinical assessment model, the fact that healthcare professionals and scientific organizations in Europe are generally negative about implementation of PGT-P due to scientific and socio-ethical concerns, implies that, even if it were legally possible, the chance that PGT-P would be offered in the near future might be low.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The results are based on our interpretation of publicly available written information and documents, therefore not all potential discrepancies between law and practice might have been identified. In addition, our analysis focuses on seven\u2014and not all\u2014European countries. However, since these countries are relevant players within PGT in Europe and since they have distinct PGT regulations, the insights gathered give relevant insights into diverse ways of PGT regulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>To the best of our knowledge, this is the first paper that provides a thorough overview of the legal and practical regulation of PGT in Europe. Our analysis of how PGT-P fits within current regulation models provides guidance for healthcare professionals and policymakers in navigating the possible future implementation of PGT-P within Europe.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(s)<\/jats:title>\n                  <jats:p>This project has received funding from the European Union\u2019s Horizon 2020 research and innovation program under the Marie Sk\u0142odowska-Curie grant agreement no. 813707. The authors declare no conflict of interest.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deae049","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T03:47:43Z","timestamp":1711079263000},"page":"1117-1130","source":"Crossref","is-referenced-by-count":15,"title":["Ready for polygenic risk scores? An analysis of regulation of preimplantation genetic testing in European countries"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-1512","authenticated-orcid":false,"given":"M","family":"Siermann","sequence":"first","affiliation":[{"name":"Centre of Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven , Leuven, Belgium"},{"name":"Department of Physiology, Faculty of Medicine, University of Helsinki , Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"van der Schoot","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus MC , Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-6222","authenticated-orcid":false,"given":"E M","family":"Bunnik","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics, Philosophy and History of Medicine, Erasmus MC , Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-9560","authenticated-orcid":false,"given":"P","family":"Borry","sequence":"additional","affiliation":[{"name":"Centre of Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven , Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"2024050205544255300_deae049-B1","doi-asserted-by":"crossref","first-page":"1765693","DOI":"10.1080\/2474736X.2020.1765693","article-title":"Secular citizens, pious MPs: why German attitudes about genetic testing are much more permissive than German laws","volume":"2","author":"Arzheimer","year":"2020","journal-title":"Political Res Exch"},{"key":"2024050205544255300_deae049-B2"},{"key":"2024050205544255300_deae049-B3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rbms.2017.01.001","article-title":"Comparative preimplantation genetic diagnosis policy in Europe and the USA and its implications for reproductive tourism","volume":"3","author":"Bayefsky","year":"2016","journal-title":"Reprod Biomed Soc Online"},{"key":"2024050205544255300_deae049-B4","author":"Belgian Advisory Committee on Bioethics","year":"2009"},{"key":"2024050205544255300_deae049-B5","author":"Belgisch Staatsblad","year":"2007"},{"key":"2024050205544255300_deae049-B6","article-title":"Patients warned against American clinics offering \u2018unethical\u2019 embryo screening","author":"Blakely","year":"2022","journal-title":"The Times"},{"key":"2024050205544255300_deae049-B7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rbms.2016.11.002","article-title":"Contested change: how Germany came to allow PGD","volume":"3","author":"Bock von Wulfingen","year":"2016","journal-title":"Reprod Biomed Soc Online"},{"key":"2024050205544255300_deae049-B8","author":"Bundesgerichtshof","year":"2010"},{"key":"2024050205544255300_deae049-B9","doi-asserted-by":"crossref","first-page":"hoz044","DOI":"10.1093\/hropen\/hoz044","article-title":"Survey on ART and IUI: legislation, regulation, funding and registries in European countries: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","volume":"2020","author":"Calhaz-Jorge","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2024050205544255300_deae049-B10","article-title":"Mendelian genetics: patterns of inheritance and single-gene disorders","volume":"1","author":"Chial","year":"2008","journal-title":"Nat Educ"},{"key":"2024050205544255300_deae049-B11","author":"Comisi\u00f3n Nacional de Reproducci\u00f3n Humana Asistida","year":"2023"},{"key":"2024050205544255300_deae049-B12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.ejhg.5201976","article-title":"Provision and quality assurance of preimplantation genetic diagnosis in Europe","volume":"16","author":"Corveleyn","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"2024050205544255300_deae049-B13","article-title":"Preimplantation genetic diagnosis in Europe","author":"Corveleyn","year":"2007"},{"key":"2024050205544255300_deae049-B14","author":"Council of Europe","year":"2015"},{"key":"2024050205544255300_deae049-B15","doi-asserted-by":"crossref","first-page":"101902","DOI":"10.1016\/j.jogoh.2020.101902","article-title":"National survey on the opinions of French specialists in assisted reproductive technologies about social issues impacting the future revision of the French Bioethics laws","volume":"49","author":"Creux","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2024050205544255300_deae049-B16","doi-asserted-by":"crossref","first-page":"A45","DOI":"10.1530\/REP-20-0082","article-title":"Clinical experience of preimplantation genetic testing","volume":"160","author":"De Rycke","year":"2020","journal-title":"Reproduction"},{"key":"2024050205544255300_deae049-B17","article-title":"Wetsvoorstel tot wijziging van de wet van 6 juli 2007 betreffende de medisch begeleide voortplanting en de bestemming van de overtallige embryo\u2019s en de gameten teneinde een uitbreiding van het toepassingsgebied van de pre-implantatiediagnostiek mogelijk te maken","author":"Defraigne","year":"2011","journal-title":"Belgische Senaat"},{"key":"2024050205544255300_deae049-B18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1163\/15718093-12420347","article-title":"Preimplantation genetic diagnosis: the situation in France and in other European countries","volume":"24","author":"Duguet","year":"2017","journal-title":"Eur J Health Law"},{"key":"2024050205544255300_deae049-B19","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.fertnstert.2021.07.717","article-title":"Rate of patients electing for polygenic risk scores in preimplantation genetic testing","volume":"116","author":"Eccles","year":"2021","journal-title":"Fertil Steril"},{"key":"2024050205544255300_deae049-B20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.fertnstert.2021.12.024","article-title":"Use of reproductive technology for sex selection for nonmedical reasons: an Ethics Committee opinion","volume":"117","author":"Ethics Committee of the American Society for Reproductive Medicine.","year":"2022","journal-title":"Fertil Steril"},{"key":"2024050205544255300_deae049-B21","year":"2022"},{"key":"2024050205544255300_deae049-B22","first-page":"757","article-title":"A comparison of international regulation of preimplantation genetic diagnosis and a regulatory suggestion for the United States","volume":"15","author":"Fahrenkrog","year":"2006","journal-title":"Transnatl Law Contemp Probs"},{"key":"2024050205544255300_deae049-B23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.rbmo.2009.11.009","article-title":"Cross-border reproductive care: a phenomenon expressing the controversial aspects of reproductive technologies","volume":"20","author":"Ferraretti","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2024050205544255300_deae049-B24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41431-021-01000-x","article-title":"The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice","volume":"30","author":"Forzano","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"2024050205544255300_deae049-B25","author":"France","year":"2004"},{"key":"2024050205544255300_deae049-B26","author":"France","year":"2011"},{"key":"2024050205544255300_deae049-B27","author":"France","year":"2021"},{"key":"2024050205544255300_deae049-B28","author":"France","year":"2021"},{"key":"2024050205544255300_deae049-B29","author":"Furrer","year":"2023"},{"key":"2024050205544255300_deae049-B30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11825-016-0102-6","article-title":"Pr\u00e4implantationsdiagnostik in den Niederlanden","volume":"28","author":"Geraedts","year":"2016","journal-title":"Medizinische Genetik"},{"key":"2024050205544255300_deae049-B31","author":"Germany","year":"1990"},{"key":"2024050205544255300_deae049-B32","author":"Germany","year":"2011"},{"key":"2024050205544255300_deae049-B33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.rbmo.2013.08.014","article-title":"Reiterative changes in the Italian regulation on IVF: the effect on PGD patients\u2019 reproductive decisions","volume":"28","author":"Gianaroli","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2024050205544255300_deae049-B34","doi-asserted-by":"crossref","first-page":"a036681","DOI":"10.1101\/cshperspect.a036681","article-title":"Regulating preimplantation genetic testing across the world: a comparison of international policy and ethical perspectives","volume":"10","author":"Ginoza","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2024050205544255300_deae049-B35","author":"Granato","year":"2021"},{"key":"2024050205544255300_deae049-B36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15388\/Teise.2022.125.4","article-title":"Legal regulation of preimplantation genetic diagnosis: a comparative analysis of the Baltic Sea region and the Nordic countries","volume":"125","author":"Grubliauskien\u0117","year":"2022","journal-title":"Teis\u0117"},{"key":"2024050205544255300_deae049-B37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/aogs.13831","article-title":"Preimplantation genetic testing legislation and accessibility in the Nordic countries","volume":"99","author":"Hreinsson","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2024050205544255300_deae049-B38","year":"2021"},{"key":"2024050205544255300_deae049-B39","author":"Human Fertilisation & Embryology Authority","year":"2023"},{"key":"2024050205544255300_deae049-B40"},{"key":"2024050205544255300_deae049-B42","author":"Human Fertilisation & Embryology Authority"},{"key":"2024050205544255300_deae049-B43","author":"Italy","year":"1978"},{"key":"2024050205544255300_deae049-B44","author":"Italy","year":"2004"},{"key":"2024050205544255300_deae049-B45","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cell.2019.10.033","article-title":"Screening human embryos for polygenic traits has limited utility","volume":"179","author":"Karavani","year":"2019","journal-title":"Cell"},{"key":"2024050205544255300_deae049-B46","first-page":"1","article-title":"\u201cIs down always out?\u201d: the right of Icelandic parents to use preimplantation genetic diagnosis to select for a disability","volume":"51","author":"Kettering","year":"2019","journal-title":"The George Washington Int Law Rev"},{"key":"2024050205544255300_deae049-B47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.12717\/DR.2015.19.2.111","article-title":"Legislation on genetic diagnosis: comparison of South Korea and Germany: - with focus on the application and communication structure","volume":"19","author":"Kim","year":"2015","journal-title":"Dev Reprod"},{"key":"2024050205544255300_deae049-B48","first-page":"38","article-title":"Preimplantation genetic diagnosis for monogenic disorders and chromosomal rearrangements\u2014the German perspective","volume":"10","author":"Koehler","year":"2013","journal-title":"J Reproduk Endokrinol"},{"key":"2024050205544255300_deae049-B49","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/03605310490514243","article-title":"Preimplantation genetic diagnosis (PGD): European perspectives and the German situation","volume":"29","author":"Krones","year":"2004","journal-title":"J Med Philos"},{"key":"2024050205544255300_deae049-B50","author":"L\u2019Agence de la biom\u00e9decine","year":"2013"},{"key":"2024050205544255300_deae049-B51","author":"L\u2019Agence de la biom\u00e9decine","year":"2022"},{"key":"2024050205544255300_deae049-B52","author":"L\u2019Agence de la biom\u00e9decine","year":"2022"},{"key":"2024050205544255300_deae049-B53","author":"La Corte Costituzionale","year":"2015"},{"key":"2024050205544255300_deae049-B54","author":"La Corte Costituzionale","year":"2015"},{"key":"2024050205544255300_deae049-B55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41436-020-01019-3","article-title":"Screening embryos for polygenic conditions and traits: ethical considerations for an emerging technology","volume":"23","author":"L\u00e1zaro-Mu\u00f1oz","year":"2021","journal-title":"Genet Med"},{"key":"2024050205544255300_deae049-B56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41598-023-27561-z","article-title":"Sibling variation in polygenic traits and DNA recombination mapping with UK Biobank and IVF family data","volume":"13","author":"Lello","year":"2023","journal-title":"Sci Rep"},{"key":"2024050205544255300_deae049-B57","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1038\/s41598-020-69927-7","article-title":"Sibling validation of polygenic risk scores and complex trait prediction","volume":"10","author":"Lello","year":"2020","journal-title":"Sci Rep"},{"key":"2024050205544255300_deae049-B58","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1016\/j.fertnstert.2021.07.062","article-title":"Polygenic risk scores, PGT-P, and IVF: sibling and non-European ancestry validations","volume":"116","author":"Lello","year":"2021","journal-title":"Fertil Steril"},{"key":"2024050205544255300_deae049-B59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/14636778.2018.1549983","article-title":"Social dimensions of preimplantation genetic diagnosis: a literature review","volume":"38","author":"Lemke","year":"2018","journal-title":"New Genet Soc"},{"key":"2024050205544255300_deae049-B60","doi-asserted-by":"crossref","first-page":"e64716","DOI":"10.7554\/eLife.64716","article-title":"Utility of polygenic embryo screening for disease depends on the selection strategy","volume":"10","author":"Lencz","year":"2021","journal-title":"Elife"},{"key":"2024050205544255300_deae049-B61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.ade1083","article-title":"Public views on polygenic screening of embryos","volume":"379","author":"Meyer","year":"2023","journal-title":"Science"},{"key":"2024050205544255300_deae049-B62","author":"Ministerie van Volksgezondheid, Welzijn en Sport","year":"2019"},{"key":"2024050205544255300_deae049-B63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2012.03.006","article-title":"Results and unsolved problems following the amendment to the Italian Law on assisted reproduction brought about by the constitutional court","volume":"163","author":"Molinelli","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2024050205544255300_deae049-B64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40246-022-00390-3","article-title":"Evaluating standards for \u2018serious\u2019 disease for preimplantation genetic testing: a multi-case study on regulatory frameworks in Japan, the UK, and Western Australia","volume":"16","author":"Nakasato","year":"2022","journal-title":"Hum Genomics"},{"key":"2024050205544255300_deae049-B65","author":"Nederlandse Overheid","year":"2021"},{"key":"2024050205544255300_deae049-B66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rbmo.2023.03.013","article-title":"Acceptance of genetic editing and of whole genome sequencing of human embryos by patients with infertility before and after the onset of the COVID-19 pandemic","volume":"47","author":"Neuhausser","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"2024050205544255300_deae049-B67","first-page":"1","volume-title":"eLS","author":"Nippert","year":"2016"},{"key":"2024050205544255300_deae049-B68","author":"Oviedo Convention","year":"1997"},{"key":"2024050205544255300_deae049-B69","first-page":"127","article-title":"The right to preimplantation genetic diagnosis: biological citizenship and the challenge to the Italian law on medically assisted reproduction","volume":"10","author":"Parfenchyk","year":"2018","journal-title":"Eur J Legal Stud"},{"key":"2024050205544255300_deae049-B70","author":"Paternotte","year":"2023"},{"key":"2024050205544255300_deae049-B71","first-page":"101","volume-title":"Assessing Life: On the Organisation of Genetic Testing","author":"Pavone","year":"2010"},{"key":"2024050205544255300_deae049-B72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0162243911411195","article-title":"Beyond the geneticization thesis: the political economy of PGD\/PGS in Spain","volume":"37","author":"Pavone","year":"2011","journal-title":"Sci Technol Hum Values"},{"key":"2024050205544255300_deae049-B73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-3-319-58220-7_6","volume-title":"Selective Reproduction in the 21st Century","author":"Pavone","year":"2018"},{"key":"2024050205544255300_deae049-B74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1163\/092902707X232971","article-title":"Belgian law on medically assisted reproduction and the disposition of supernumerary embryos and gametes","volume":"14","author":"Pennings","year":"2007","journal-title":"Eur J Health Law"},{"key":"2024050205544255300_deae049-B75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-816468-6.00013-8","volume-title":"Human Embryos and Preimplantation Genetic Technologies","author":"Pennings","year":"2019"},{"key":"2024050205544255300_deae049-B76","author":"PGT Nederland","year":"2020"},{"key":"2024050205544255300_deae049-B77","author":"PGT Nederland","year":"2023"},{"key":"2024050205544255300_deae049-B78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-3-319-16892-0_26","volume-title":"Screening the Single Euploid Embryo: Molecular Genetics in Reproductive Medicine","author":"S\u00e1ndor","year":"2015"},{"key":"2024050205544255300_deae049-B79","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/humrep\/deg110","article-title":"Taskforce 5: preimplantation genetic diagnosis","volume":"18","author":"Shenfield","year":"2003","journal-title":"Hum Reprod"},{"key":"2024050205544255300_deae049-B80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12687-021-00573-w","article-title":"A systematic review of the views of healthcare professionals on the scope of preimplantation genetic testing","volume":"13","author":"Siermann","year":"2022","journal-title":"J Community Genet"},{"key":"2024050205544255300_deae049-B81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.gim.2022.03.001","article-title":"A review of normative documents on preimplantation genetic testing: recommendations for PGT-P","volume":"24","author":"Siermann","year":"2022","journal-title":"Genet Med"},{"key":"2024050205544255300_deae049-B82","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41431-023-01333-9","article-title":"Limitations, concerns and potential: attitudes of healthcare professionals toward preimplantation genetic testing using polygenic risk scores","volume":"31","author":"Siermann","year":"2023","journal-title":"Eur J Hum Genet"},{"key":"2024050205544255300_deae049-B83","doi-asserted-by":"crossref","first-page":"116599","DOI":"10.1016\/j.socscimed.2024.116599","article-title":"\u201cAre we not going too far?\u201d: socio-ethical considerations of preimplantation genetic testing using polygenic risk scores according to healthcare professionals","volume":"343","author":"Siermann","year":"2024","journal-title":"Soc Sci Med"},{"key":"2024050205544255300_deae049-B84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-8889-1_2","volume-title":"Prenatal Diagnosis","author":"Simpson","year":"2019"},{"key":"2024050205544255300_deae049-B85","author":"Societ\u00e0 Italiana di Genetica Umana","year":"2017"},{"key":"2024050205544255300_deae049-B86","first-page":"309","article-title":"Preimplantation genetic diagnosis (PGD) in Europe: diversity of legislation a challenge to the community and its citizens","volume":"26","author":"Soini","year":"2007","journal-title":"Med Law"},{"key":"2024050205544255300_deae049-B87","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.ejhg.5201598","article-title":"The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues","volume":"14","author":"Soini","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"2024050205544255300_deae049-B88","author":"Spain","year":"1988"},{"key":"2024050205544255300_deae049-B89","author":"Spain","year":"2006"},{"key":"2024050205544255300_deae049-B90","author":"The Netherlands","year":"2002"},{"key":"2024050205544255300_deae049-B91","author":"The Netherlands","year":"2009"},{"key":"2024050205544255300_deae049-B92","author":"The Netherlands","year":"2013"},{"key":"2024050205544255300_deae049-B93","author":"The United Kingdom","year":"1990"},{"key":"2024050205544255300_deae049-B94","author":"The United Kingdom","year":"2008"},{"key":"2024050205544255300_deae049-B95","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3389\/fendo.2019.00845","article-title":"Utility and first clinical application of screening embryos for polygenic disease risk reduction","volume":"10","author":"Treff","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024050205544255300_deae049-B96","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/genes11060648","article-title":"Preimplantation genetic testing for polygenic disease relative risk reduction: evaluation of genomic index performance in 11,883 adult sibling pairs","volume":"11","author":"Treff","year":"2020","journal-title":"Genes (Basel)"},{"key":"2024050205544255300_deae049-B97","doi-asserted-by":"crossref","first-page":"103647","DOI":"10.1016\/j.ejmg.2019.04.004","article-title":"Validation of concurrent preimplantation genetic testing for polygenic and monogenic disorders, structural rearrangements, and whole and segmental chromosome aneuploidy with a single universal platform","volume":"62","author":"Treff","year":"2019","journal-title":"Eur J Med Genet"},{"key":"2024050205544255300_deae049-B98","doi-asserted-by":"crossref","first-page":"c3741","DOI":"10.1136\/bmj.c3741","article-title":"Court allows preimplantation genetic diagnosis in Germany","volume":"341","author":"Tuffs","year":"2010","journal-title":"BMJ"},{"key":"2024050205544255300_deae049-B99","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr2105065","article-title":"Problems with using polygenic scores to select embryos","volume":"385","author":"Turley","year":"2021","journal-title":"N Engl J Med"},{"key":"2024050205544255300_deae049-B100","first-page":"1013","article-title":"Pre-implantation genetic diagnosis in accordance with Italian regulations","volume":"1","author":"Vesto","year":"2017","journal-title":"J Clin Obstet Gynecol Infertil"},{"key":"2024050205544255300_deae049-B101","first-page":"18173","volume-title":"Scientific Rep","author":"Widen","year":"2022"},{"key":"2024050205544255300_deae049-B102","author":"Winter","year":"2012"},{"key":"2024050205544255300_deae049-B103","doi-asserted-by":"crossref","first-page":"113796","DOI":"10.1016\/j.socscimed.2021.113796","article-title":"Public attitudes toward genetic risk scoring in medicine and beyond","volume":"274","author":"Zhang","year":"2021","journal-title":"Soc Sci Med"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/5\/1117\/57365700\/deae049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/5\/1117\/57365700\/deae049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T05:58:28Z","timestamp":1714629508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/39\/5\/1117\/7633417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":102,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,21]]},"published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deae049","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2024,3,21]]}}}